News
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.
CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results